SIRT1 and breast cancer: Similar study performed on mouse xenograft model demonstrated that SIRT1 inhibition by EX257 enhances the sensitivity of HPV+ head and neck cancer cells to genotoxic agents, including cisplatin47, showing that EX257 display similar activity against different cancer types in vivo, and not restricted to BC only.